Published on:

Abbott’s Appeal of $1.67 Billion Verdict

By

These runaway juries are unreal. They are constantly finding in favor of plaintiffs who are essentially faking injuries instead of expressing gratitude for the life altering medications pharmaceutical companies make. Abbott Laboratories is now fighting one of these runaway verdicts on appeal after a jury awarded the plaintiff $1.67 billion.
Oh, wait. The Plaintiff was not claiming to be injured. The Plaintiff was pharmaceutical titan Johnson & Johnson who was awarded $1.67 billion for patent infringement regarding the arthritis drug Humira which, ironically is under attack for the side effects it causes and now has a black box warning.
I suggest this defense for Abbott. The FDA approved Humira. If the FDA thought it infringed on a patent, it would have said so. Patent infringement preemption.